** Shares of Artrya fall as much 9% to A$0.455, their lowest level since Oct 23

** The medical technology co receives firm commitments to raise A$5 mln ($3.29 mln) via placement

** Issue price of A$0.42 represents 16% discount to co's last close on Thursday, Nov. 7

** Adds, fund raised to be allocated to product development, others, as co awaits FDA clearance on its patented Salix Coronary Anatomy product

** Stock up 95.8% this year, including session's moves

($1 = 1.5221 Australian dollars)

(Reporting by Sherin Sunny in Bengaluru)

((Sherin.Sunny@thomsonreuters.com))